Number of items: 4.
2026
Tesini, G. et al.
(2026)
Longitudinal liquid biopsy and matched radiomic analysis of patients with biliary tract cancer undergoing systemic treatment.
Clinical Cancer Research,
(doi: 10.1158/1078-0432.CCR-26-1550)
(PMID:42820828)
(Early Online Publication)
Izquierdo-Sanchez, L. et al.
(2026)
Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry.
Journal of Hepatology,
(doi: 10.1016/j.jhep.2026.08.020)
(PMID:42637053)
(Early Online Publication)
Tesini, G. et al.
(2026)
IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancers.
JHEP Reports, 8(8),
101899.
(doi: 10.1016/j.jhepr.2026.101899)
(PMID:42167507)
2025
Tesini, Giulia, Ibrahim, Halima, Rimassa, Lorenza and Braconi, Chiara
ORCID: https://orcid.org/0000-0003-4835-1259
(2025)
Evolving precision: updates in targeted therapy for cholangiocarcinoma.
Hepatology,
(doi: 10.1097/HEP.0000000000001541)
(PMID:40982790)
(Early Online Publication)
This list was generated on Wed Oct 21 04:09:57 2026 BST.